Victoria Pelak
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 10 | 2024 | 513 | 3.190 |
Why?
| Vision Disorders | 13 | 2023 | 135 | 2.870 |
Why?
| Neurodegenerative Diseases | 4 | 2022 | 99 | 2.090 |
Why?
| Eye Movements | 3 | 2021 | 56 | 1.370 |
Why?
| Atrophy | 6 | 2024 | 164 | 1.360 |
Why?
| Cerebral Cortex | 6 | 2022 | 416 | 1.250 |
Why?
| Cerebral Amyloid Angiopathy | 1 | 2024 | 10 | 0.970 |
Why?
| Eye Diseases | 2 | 2020 | 77 | 0.950 |
Why?
| Lewy Body Disease | 2 | 2020 | 15 | 0.900 |
Why?
| Cognitive Dysfunction | 3 | 2023 | 301 | 0.870 |
Why?
| Tremor | 2 | 2021 | 46 | 0.830 |
Why?
| Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 9 | 0.810 |
Why?
| Nervous System Diseases | 2 | 2020 | 261 | 0.810 |
Why?
| Ocular Motility Disorders | 4 | 2018 | 27 | 0.810 |
Why?
| Visual Perception | 2 | 2022 | 141 | 0.790 |
Why?
| Fragile X Syndrome | 1 | 2021 | 80 | 0.770 |
Why?
| Macular Degeneration | 1 | 2022 | 151 | 0.740 |
Why?
| Reading | 1 | 2021 | 157 | 0.730 |
Why?
| Mucolipidoses | 1 | 2019 | 7 | 0.720 |
Why?
| Tomography, Optical Coherence | 4 | 2022 | 126 | 0.710 |
Why?
| Visual Pathways | 3 | 2018 | 43 | 0.690 |
Why?
| Pneumonia, Viral | 2 | 2020 | 348 | 0.650 |
Why?
| Coronavirus Infections | 2 | 2020 | 339 | 0.650 |
Why?
| Dementia | 2 | 2011 | 208 | 0.640 |
Why?
| Betacoronavirus | 2 | 2020 | 254 | 0.640 |
Why?
| Migraine Disorders | 1 | 2018 | 79 | 0.610 |
Why?
| Visual Fields | 5 | 2022 | 78 | 0.600 |
Why?
| Ophthalmology | 1 | 2018 | 80 | 0.600 |
Why?
| Neurology | 1 | 2018 | 94 | 0.600 |
Why?
| Androgens | 1 | 2016 | 167 | 0.510 |
Why?
| Aging | 3 | 2023 | 1670 | 0.500 |
Why?
| Magnetic Resonance Imaging | 10 | 2024 | 3174 | 0.490 |
Why?
| Optic Neuropathy, Ischemic | 3 | 2012 | 29 | 0.470 |
Why?
| Testosterone | 1 | 2016 | 351 | 0.440 |
Why?
| Pandemics | 2 | 2020 | 1355 | 0.440 |
Why?
| Humans | 47 | 2024 | 118972 | 0.420 |
Why?
| Cognition | 2 | 2023 | 1024 | 0.370 |
Why?
| Optic Nerve Diseases | 2 | 2009 | 32 | 0.360 |
Why?
| Optic Neuritis | 3 | 2020 | 37 | 0.360 |
Why?
| Inflammation | 1 | 2020 | 2566 | 0.350 |
Why?
| Myelin-Oligodendrocyte Glycoprotein | 2 | 2020 | 44 | 0.350 |
Why?
| Vision, Low | 1 | 2009 | 14 | 0.350 |
Why?
| Optic Nerve | 1 | 2009 | 65 | 0.340 |
Why?
| Giant Cell Arteritis | 3 | 2020 | 47 | 0.310 |
Why?
| Brain Diseases | 2 | 2017 | 140 | 0.300 |
Why?
| Congresses as Topic | 2 | 2019 | 204 | 0.300 |
Why?
| Visual Acuity | 6 | 2022 | 272 | 0.290 |
Why?
| Cataract Extraction | 1 | 2006 | 82 | 0.260 |
Why?
| Nerve Net | 2 | 2022 | 232 | 0.250 |
Why?
| Male | 23 | 2024 | 57801 | 0.250 |
Why?
| Pseudotumor Cerebri | 2 | 2016 | 22 | 0.250 |
Why?
| Aged | 11 | 2023 | 19657 | 0.240 |
Why?
| Cognition Disorders | 2 | 2023 | 529 | 0.240 |
Why?
| Cerebral Hemorrhage | 1 | 2024 | 100 | 0.230 |
Why?
| Cognitive Aging | 1 | 2023 | 14 | 0.220 |
Why?
| Middle Aged | 17 | 2024 | 27617 | 0.220 |
Why?
| Immunosuppressive Agents | 4 | 2020 | 681 | 0.220 |
Why?
| Lewy Bodies | 1 | 2022 | 4 | 0.220 |
Why?
| Unconsciousness | 1 | 2022 | 24 | 0.210 |
Why?
| Amnesia | 2 | 2012 | 46 | 0.210 |
Why?
| Ataxia | 1 | 2021 | 38 | 0.210 |
Why?
| Neuropsychological Tests | 3 | 2022 | 1032 | 0.210 |
Why?
| Diffusion Tensor Imaging | 2 | 2023 | 73 | 0.200 |
Why?
| Retinal Ganglion Cells | 1 | 2022 | 92 | 0.200 |
Why?
| Female | 22 | 2024 | 61564 | 0.200 |
Why?
| White Matter | 1 | 2023 | 115 | 0.200 |
Why?
| Trochlear Nerve Diseases | 1 | 2001 | 6 | 0.200 |
Why?
| Fragile X Mental Retardation Protein | 1 | 2021 | 65 | 0.200 |
Why?
| Oculomotor Nerve Diseases | 1 | 2001 | 9 | 0.200 |
Why?
| Abducens Nerve Diseases | 1 | 2001 | 10 | 0.200 |
Why?
| Stents | 2 | 2016 | 457 | 0.190 |
Why?
| Myasthenia Gravis | 1 | 2020 | 19 | 0.190 |
Why?
| Brain | 6 | 2023 | 2490 | 0.180 |
Why?
| Autonomic Fibers, Preganglionic | 1 | 1999 | 4 | 0.180 |
Why?
| Siderosis | 1 | 1999 | 3 | 0.180 |
Why?
| Pupil | 1 | 1999 | 13 | 0.180 |
Why?
| Eye Movement Measurements | 1 | 2019 | 11 | 0.180 |
Why?
| Immunomodulation | 1 | 2020 | 89 | 0.180 |
Why?
| West Nile Fever | 1 | 2020 | 51 | 0.180 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 143 | 0.180 |
Why?
| Brain Stem | 1 | 2000 | 104 | 0.180 |
Why?
| Retrospective Studies | 7 | 2024 | 12978 | 0.180 |
Why?
| Diagnostic Techniques, Ophthalmological | 1 | 2019 | 36 | 0.180 |
Why?
| Hearing Loss | 1 | 2023 | 186 | 0.180 |
Why?
| Steroids | 1 | 2020 | 153 | 0.180 |
Why?
| Facial Recognition | 1 | 2019 | 27 | 0.170 |
Why?
| Immune System | 1 | 2020 | 181 | 0.170 |
Why?
| San Francisco | 1 | 2018 | 57 | 0.170 |
Why?
| Frontotemporal Dementia | 1 | 2019 | 32 | 0.170 |
Why?
| Facial Expression | 1 | 2019 | 62 | 0.160 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2018 | 43 | 0.160 |
Why?
| Vestibule, Labyrinth | 1 | 2018 | 54 | 0.160 |
Why?
| Epilepsy, Temporal Lobe | 1 | 2017 | 20 | 0.150 |
Why?
| Transverse Sinuses | 1 | 2016 | 8 | 0.150 |
Why?
| Critical Care | 1 | 2021 | 492 | 0.150 |
Why?
| Papilledema | 2 | 2018 | 36 | 0.140 |
Why?
| Adult | 13 | 2022 | 31512 | 0.140 |
Why?
| Immunotherapy | 1 | 2020 | 493 | 0.140 |
Why?
| Universities | 1 | 2018 | 347 | 0.140 |
Why?
| Case-Control Studies | 2 | 2021 | 3171 | 0.140 |
Why?
| Laser Therapy | 1 | 2017 | 104 | 0.140 |
Why?
| Postoperative Complications | 1 | 2006 | 2235 | 0.130 |
Why?
| Amygdala | 1 | 2017 | 175 | 0.130 |
Why?
| Brain Mapping | 3 | 2022 | 532 | 0.130 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 969 | 0.120 |
Why?
| Parkinson Disease | 1 | 2018 | 334 | 0.120 |
Why?
| Biomarkers | 2 | 2024 | 3588 | 0.120 |
Why?
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 90 | 0.110 |
Why?
| Multiple Sclerosis | 3 | 2020 | 384 | 0.110 |
Why?
| Biomedical Research | 1 | 2019 | 612 | 0.110 |
Why?
| Optic Disk Drusen | 1 | 2012 | 5 | 0.110 |
Why?
| Autoantibodies | 2 | 2018 | 1335 | 0.110 |
Why?
| Hippocampus | 1 | 2017 | 735 | 0.110 |
Why?
| Visual Field Tests | 1 | 2011 | 14 | 0.110 |
Why?
| Cranial Sinuses | 1 | 2011 | 13 | 0.110 |
Why?
| Optic Disk | 2 | 2009 | 36 | 0.100 |
Why?
| Hemianopsia | 1 | 2011 | 10 | 0.100 |
Why?
| Hemodynamics | 1 | 2016 | 1003 | 0.100 |
Why?
| Memory, Episodic | 1 | 2012 | 42 | 0.100 |
Why?
| Quality of Life | 1 | 2022 | 2366 | 0.100 |
Why?
| Diagnosis, Differential | 3 | 2009 | 1384 | 0.090 |
Why?
| Neurosurgical Procedures | 1 | 2011 | 164 | 0.090 |
Why?
| Nervous System Malformations | 1 | 2009 | 33 | 0.080 |
Why?
| Hypokinesia | 1 | 2008 | 7 | 0.080 |
Why?
| Stiff-Person Syndrome | 1 | 2008 | 7 | 0.080 |
Why?
| Age of Onset | 2 | 2020 | 467 | 0.080 |
Why?
| Rest | 2 | 2022 | 104 | 0.070 |
Why?
| Arteritis | 1 | 2006 | 27 | 0.070 |
Why?
| Spinal Nerve Roots | 1 | 2005 | 30 | 0.070 |
Why?
| Cranial Nerve Diseases | 1 | 2005 | 42 | 0.060 |
Why?
| Animals | 4 | 2023 | 33381 | 0.060 |
Why?
| Peripheral Nervous System Diseases | 1 | 2005 | 122 | 0.060 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1868 | 0.060 |
Why?
| Blindness, Cortical | 1 | 2003 | 5 | 0.060 |
Why?
| Gliosis | 1 | 2023 | 35 | 0.060 |
Why?
| Neurites | 1 | 2023 | 45 | 0.060 |
Why?
| Adolescent | 6 | 2020 | 18480 | 0.060 |
Why?
| Demography | 1 | 2024 | 274 | 0.060 |
Why?
| Young Adult | 4 | 2022 | 10793 | 0.050 |
Why?
| Pulvinar | 1 | 2022 | 4 | 0.050 |
Why?
| Follow-Up Studies | 3 | 2017 | 4596 | 0.050 |
Why?
| Amyloid beta-Peptides | 1 | 2024 | 200 | 0.050 |
Why?
| Diplopia | 1 | 2001 | 16 | 0.050 |
Why?
| Pre-Eclampsia | 1 | 2003 | 183 | 0.050 |
Why?
| Connectome | 1 | 2022 | 63 | 0.050 |
Why?
| Neuroimaging | 1 | 2023 | 256 | 0.050 |
Why?
| Functional Laterality | 1 | 2022 | 208 | 0.050 |
Why?
| Strabismus | 1 | 2001 | 27 | 0.050 |
Why?
| Treatment Failure | 2 | 2016 | 341 | 0.050 |
Why?
| Vision Tests | 1 | 2000 | 15 | 0.050 |
Why?
| Cohort Studies | 2 | 2024 | 5116 | 0.050 |
Why?
| Vision, Ocular | 1 | 2000 | 32 | 0.050 |
Why?
| Immunization, Passive | 1 | 2020 | 81 | 0.050 |
Why?
| Temporal Lobe | 2 | 2012 | 90 | 0.050 |
Why?
| Demyelinating Diseases | 1 | 2020 | 79 | 0.040 |
Why?
| New Orleans | 1 | 2019 | 13 | 0.040 |
Why?
| Eye Pain | 1 | 2018 | 7 | 0.040 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 55 | 0.040 |
Why?
| Encephalitis | 1 | 2020 | 129 | 0.040 |
Why?
| Antirheumatic Agents | 1 | 2020 | 254 | 0.040 |
Why?
| Recurrence | 1 | 2020 | 975 | 0.040 |
Why?
| Focus Groups | 1 | 2018 | 387 | 0.040 |
Why?
| Transfection | 1 | 2018 | 888 | 0.030 |
Why?
| HEK293 Cells | 1 | 2018 | 625 | 0.030 |
Why?
| Child, Preschool | 2 | 2020 | 9491 | 0.030 |
Why?
| Hospital Mortality | 1 | 1999 | 814 | 0.030 |
Why?
| Flow Cytometry | 1 | 2018 | 1085 | 0.030 |
Why?
| Patient Participation | 1 | 2018 | 369 | 0.030 |
Why?
| Immunoglobulin G | 1 | 2018 | 788 | 0.030 |
Why?
| Emotions | 1 | 2019 | 495 | 0.030 |
Why?
| Child | 3 | 2020 | 19129 | 0.030 |
Why?
| Qualitative Research | 1 | 2018 | 953 | 0.030 |
Why?
| Colorado | 1 | 2022 | 4196 | 0.030 |
Why?
| Disease Management | 1 | 2016 | 571 | 0.030 |
Why?
| Color Vision Defects | 1 | 2012 | 6 | 0.030 |
Why?
| Spinal Puncture | 1 | 2012 | 16 | 0.030 |
Why?
| Phlebography | 1 | 2011 | 40 | 0.030 |
Why?
| Cerebral Angiography | 1 | 2011 | 116 | 0.030 |
Why?
| Lymphokines | 1 | 1991 | 122 | 0.020 |
Why?
| Stroke | 1 | 1999 | 1047 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2022 | 4708 | 0.020 |
Why?
| Hospitalization | 1 | 1999 | 1785 | 0.020 |
Why?
| Phenotype | 1 | 2018 | 3003 | 0.020 |
Why?
| Autoradiography | 1 | 1989 | 72 | 0.020 |
Why?
| Supranuclear Palsy, Progressive | 1 | 2008 | 6 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1293 | 0.020 |
Why?
| T-Lymphocyte Subsets | 1 | 1991 | 396 | 0.020 |
Why?
| Brain Chemistry | 1 | 1989 | 119 | 0.020 |
Why?
| Blindness | 1 | 2008 | 35 | 0.020 |
Why?
| Saccades | 1 | 2008 | 51 | 0.020 |
Why?
| Macaca mulatta | 1 | 1989 | 153 | 0.020 |
Why?
| Oculomotor Muscles | 1 | 2008 | 42 | 0.020 |
Why?
| Withholding Treatment | 1 | 2008 | 67 | 0.020 |
Why?
| Killer Cells, Natural | 1 | 1991 | 381 | 0.020 |
Why?
| Glutamate Decarboxylase | 1 | 2008 | 159 | 0.020 |
Why?
| Frontal Lobe | 1 | 1989 | 148 | 0.020 |
Why?
| Immunoglobulins, Intravenous | 1 | 2008 | 128 | 0.020 |
Why?
| gamma-Aminobutyric Acid | 1 | 2008 | 155 | 0.020 |
Why?
| Neural Inhibition | 1 | 2008 | 160 | 0.020 |
Why?
| Pilot Projects | 1 | 2012 | 1419 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 1991 | 1067 | 0.020 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1991 | 632 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2011 | 1795 | 0.020 |
Why?
| Electromyography | 1 | 2008 | 326 | 0.020 |
Why?
| Treatment Outcome | 2 | 2011 | 9342 | 0.020 |
Why?
| Cranial Nerves | 1 | 2005 | 11 | 0.020 |
Why?
| Sural Nerve | 1 | 2005 | 20 | 0.020 |
Why?
| Nerve Fibers, Myelinated | 1 | 2005 | 46 | 0.020 |
Why?
| Graves Disease | 1 | 2005 | 32 | 0.020 |
Why?
| Hypertrophy | 1 | 2005 | 121 | 0.020 |
Why?
| Amino Acids | 1 | 1989 | 464 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2011 | 2874 | 0.010 |
Why?
| Myelin Sheath | 1 | 2005 | 148 | 0.010 |
Why?
| Axons | 1 | 2005 | 185 | 0.010 |
Why?
| Mice | 1 | 2020 | 15520 | 0.010 |
Why?
| Disease Progression | 1 | 2008 | 2490 | 0.010 |
Why?
| Contrast Sensitivity | 1 | 2000 | 13 | 0.010 |
Why?
| Observer Variation | 1 | 2000 | 309 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2008 | 1515 | 0.010 |
Why?
| Reference Values | 1 | 2000 | 774 | 0.010 |
Why?
| Walking | 1 | 2000 | 415 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2003 | 2436 | 0.010 |
Why?
| Age Factors | 1 | 1999 | 2995 | 0.010 |
Why?
| Pregnancy | 1 | 2003 | 5690 | 0.010 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 83 | 0.010 |
Why?
| Blotting, Northern | 1 | 1991 | 194 | 0.010 |
Why?
| Antigens, Differentiation | 1 | 1991 | 79 | 0.010 |
Why?
| Receptors, IgG | 1 | 1991 | 67 | 0.010 |
Why?
| CD3 Complex | 1 | 1991 | 92 | 0.010 |
Why?
| Receptors, Fc | 1 | 1991 | 48 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 102 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 310 | 0.010 |
Why?
| Base Sequence | 1 | 1991 | 2159 | 0.000 |
Why?
| Molecular Sequence Data | 1 | 1991 | 2871 | 0.000 |
Why?
| Gene Expression | 1 | 1991 | 1489 | 0.000 |
Why?
| RNA | 1 | 1991 | 833 | 0.000 |
Why?
|
|
Pelak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|